{
 "as_of": "2026-11-02",
 "count": 1,
 "disclaimer": "Factual summary of public SEC filings. Not investment advice. Verify in the original filing.",
 "rows": [
  {
   "accession": "0001493152-26-049298",
   "appeal_by": "2026-10-30",
   "cik": "1517681",
   "company": "Propanc Biopharma, Inc.",
   "days_remaining": -3,
   "deadline": "2026-10-30",
   "deadline_type": "hearing request due",
   "deficiency": "minimum bid price, low share price (≤$0.10) / reverse-split limits",
   "delisting_date": "2026-11-02",
   "exchange": "Nasdaq",
   "filed": "2026-10-29",
   "filing_url": "https://www.sec.gov/Archives/edgar/data/1517681/000149315226049298/0001493152-26-049298-index.htm",
   "filings": 1,
   "history": [],
   "notice_date": "2026-10-23",
   "panel": "company says it requested / will request a hearing",
   "status": "Delisting determination (no compliance period) (stated date passed; no later Item 3.01 filing found)",
   "summary": "Nasdaq delisting determination (minimum bid price) (no compliance period available); delisting set for November 2, 2026; appeal/hearing request due October 30, 2026; company has requested / intends to request a hearing.",
   "suspension_date": null,
   "ticker": "PPCB",
   "type": "no_compliance_period"
  }
 ],
 "source": "SEC EDGAR 8-K Item 3.01 filings",
 "window_days": 90
}